Smart Rabbit Anti Human Kcnq1 Polyclonal Affinity Purified (pbs With 0.02% Sodium Azide, 50% Glycerol, Ph7.3) (western Blot) Device [W94gemyk]

Rabbit Anti Human KCNQ1 Polyclonal Antibody

The Rabbit Anti Human KCNQ1 Polyclonal Antibody from Innovative Research is a highly purified, liquid-form polyclonal antibody designed for use in Western Blot analysis. This antibody is specifically tailored to detect and bind to the human KCNQ1 protein, a crucial component of voltage-gated potassium channels essential for the repolarization phase of the cardiac action potential. With its affinity purification process, this antibody ensures maximum specificity and sensitivity, providing reliable results in your research studies. Key features include:

• Host: Rabbit
• Species: Human, Mouse
• Target: KCNQ1
• Clonality: Polyclonal
• Purity: Affinity Purified
• Immunogen: Recombinant fusion protein of human KCNQ1

Product Specifications and Storage

This antibody is formulated in PBS with 0.02% sodium azide and 50% glycerol, ensuring stability and ease of use. It is stored at -20°C to maintain its integrity, and it should be avoided from freeze/thaw cycles to prevent degradation. The use of this antibody in Western Blot allows for clear and consistent detection of KCNQ1, supporting your research in cardiology, genetics, and related fields. Key specifications include:

• Storage Conditions: -20°C
• Buffer: PBS with 0.02% sodium azide, 50% glycerol, pH 7.3
• Immunogen: Recombinant fusion protein of human KCNQ1 (NP_861463.1)

Applications and Benefits

The Rabbit Anti Human KCNQ1 Polyclonal Antibody is an invaluable tool for researchers studying genetic disorders such as hereditary long QT syndrome 1, Jervell and Lange-Nielsen syndrome, and familial atrial fibrillation. This antibody's ability to detect KCNQ1 mutations and its role in tissue-specific imprinting make it an essential component of analytical tools like Western Blot. By utilizing this product, researchers can gain a deeper understanding of cardiac electrophysiology and the impact of gene mutations on human health. Target audience includes:

• Cardiologists
• Genetic researchers
• Pharmacologists
• Biotechnology professionals